Aquestive Therapeutics Inc. (AQST) Reports In-Line Q3 EPS

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $12.81 million versus the consensus estimate of $12.7 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• GameStop CEO Cohen buys 1.15M shares
• Sun Life to consolidate preferred shares Series 11QR into Series 10R
• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar